PharmaPlanter Technologies

PharmaPlanter Technologies is a platform biotechnology company headquartered in Burnaby, British Columbia, Canada. Founded in 2017, the company specializes in bridging the gap between early-stage scientific discovery and clinical development through its integrated technology platforms. PharmaPlanter offers a comprehensive suite of services, including pre-clinical CRO solutions, recombinant protein engineering, and antibody development. Their proprietary technologies include a TCR-pMHC AI engine for neoantigen prediction and Gas Vesicle (GV) technology for therapeutic applications. Additionally, the company operates a biotech incubator that provides infrastructure, mentorship, and strategic guidance to emerging life science ventures. PharmaPlanter's internal research focuses on oncology, metabolic diseases, and regenerative medicine, with a particular emphasis on targets like BMP9 and eIF4E.